E Fund Management (HK)’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

E Fund Management (HK)’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-22,666	Closed	-$318K	–	36
2022 Q1	$318K	Buy	22,666 +13,171	+139%	+$338K	0.2%	37
2021 Q4	$450K	Buy	+9,495	New	+$570K	0.25%	28
2021 Q2	$694K	Buy	+8,266	New	+$545K	0.43%	30

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

E Fund Management (HK)'s NBP Position: Q2 2022 in Review

E Fund Management (HK) sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2022, closing a stake of 22,666 shares — an estimated $318K sold.

E Fund Management (HK) first reported a position in NBP in Q2 2021 and held it in 3 quarters. The position peaked at $694K in Q2 2021. 97 funds tracked by Wall St. Rank hold NBP as of Q2 2022.

E Fund Management (HK) reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2022 after selling out during the quarter.
E Fund Management (HK) sold 22,666 NovaBridge Biosciences American Depositary Shares shares in Q2 2022, an estimated $318K.
E Fund Management (HK) first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 3 quarters.
E Fund Management (HK)'s NovaBridge Biosciences American Depositary Shares position peaked at $694K in Q2 2021.
97 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2022.

Based on E Fund Management (HK)'s 13F filing for Q2 2022, filed 13 Jul 2022.